…languishing because there is little money in it!

This scientific breakthrough cancer treatment is non-toxic and effective. But it has been languishing for more than 25 years because it cannot be patented and is very low-cost.

It really is true! Please read on…

This cancer therapy is based on blocking a critical enzyme in uncontrolled cell growth, Ribonucleotide Reductase (RR), which converts building blocks of RNA into DNA. The free-radical (lone electron) at the active-site of enzyme RR can be quenched (paired-up) by a stream of electrons or low-level electric current. Thus gentle electrotherapy would disable enzyme RR and arrest cancer growth. Alas, this therapy would cripple the cash flow of cancer institutions; hence they won’t touch it!

My two scientific publications, in 1997 and 2014, describe the theoretical basis of this (GEIPE) cancer treatment along with ample supporting experimental evidence, with both animals and humans:
Breakthrough Cancer Treatment – 1997 Publication => (Click here)
Breakthrough Cancer Treatment – 2014 Publication => (Click here)

Top research institutions like National Cancer Institute and MD Anderson Cancer Center have acknowledged the validity of this approach to treat cancer. See:
June 1994 Letter of MD Anderson Cancer Center, Houston, USA

It states: “… the [electrotherapy] information are interesting and deserving of further investigation.”… “We will keep the material on file should opportunities arise to study the effects of electric currents on regression of tumors.”

That “opportunity” has not come in more than 25 years, though funds needed to explore electrotherapy would be miniscule. (I have written to hundreds of cancer institutions around the world; MD Anderson Cancer Center was one of the very few that responded.) Self-preservation! Chemo and radiation oncologists don’t want to lose their jobs, do they?

This cancer therapy should be applicable to all cancers since malignant cells in any tissue need to synthesize their DNA to grow. At molecular level, cancer is a single disease!


Scientific Proof of Efficacy of This Treatment:

The very first cancer electrotherapy study was published in 1959 in journal ‘Science’. In it, two Johns Hopkins scientists reported “total regression” of tumor in 60% of mice, which was highly remarkable for a maiden study.
Breakthrough Cancer Treatment – Journal ‘Science’ Article (1959)
Mysteriously, authors did not do follow-up studies.

In 1985, a study published in preeminent journal ‘Cancer Research’ reported up to 98% tumor-shrinkage – virtual cure – after only 5 hours of gentle electrotherapy over 5 days.
Breakthrough Cancer Treatment – Journal ‘Cancer Research’ Article (1985)

Despite such positive results, further funding was denied. Please see response of the lead author to me:
Letter of Author Dr MA Herbert of the Remarkable 1985 “Cancer Research” Study
Together, we applied for a grant from CapCure Foundation but were turned down.


Help of National Cancer Institute; Inaction by City of Hope:

In 1994, National Cancer Institute found my ideas “very interesting” and referred me to Dr. Chou of City of Hope Medical Center (near LA) who was working with electric currents.
May 1994 Letter of National Cancer Institute, USA

A colleague of Dr. Chou, Dr. Y. Yen – PhD and MD, who had just moved from Yale — happened to be working with enzyme RR. He fully agreed with my premise. But City of Hope management nixed the collaboration, as the therapy would not bring [moneyed] patients.
Details of meeting at City of Hope National Medical Center

Dr. Y. Yen continued to work on enzyme RR, publishing dozens of papers — and touting its inhibition an important aim in anti-cancer chemo-therapeutic drug design.
Ribonucleotide reductase inhibitors and future drug design

Such chemo drugs have limited effectiveness and high toxicity. Dr. Yen DOES NOT MENTION that the enzyme RR can be easily disabled – in non-toxic way – by mild electric current.

He recently became president of Taipei Medical University, Taiwan. In May 2016, I sent him my two publications, and implored him to explore and standardize the therapy. He was “glad to know your good progress…” but claimed “I moved to Taiwan and no longer work on this project.”

How? In 2016, he published at least two papers on enzyme RR. The Taipei Medical University has a large “Center for Cancer Research” with 25+ scientists, including Dr. Yun Yen. Do cancer researchers not work on finding better treatments? Otherwise WHAT DO THEY DO?


Universality of GEIPE Cancer Treatment:

This cancer therapy should be applicable to all cancers since malignant cells in any tissue need to synthesize their DNA to grow. At molecular level, cancer is a single disease!

We offer our GEIPE device for only visible/palpable cancers, simply because they can be treated as a home-remedy, without any assistance from a medical professional. Otherwise, the principle of GEIPE treatment (use of gentle electricity) is universally applicable, as shown by the following 2 examples.

Already in use to treat brain and spinal cord tumors:

See this link at webmd.com: FDA Approves New Electrical Fields Device for Brain Tumor Treatment
And, this link at cancer.org: Alternating Electric Field Therapy for Adult Brain & Spinal Cord Tumors

Proven effective for leukemia using The Kanzius Machine:

The esteemed news-magazine “60 Minutes” of CBS has broadcast two episodes on The Kanzius Machine for treating cancer.
Apr. 2008 Episode of “60 Minutes” about Kanzius Machine 
Oct. 2009 Episode of “60 Minutes” about Kanzius Machine

A radio engineer John Kanzius, suffering from leukemia, built a machine that uses radio waves to produce a stream of electrons (RF current) as indicated by lighting-up of a fluorescent tube put in the path. Both he and Dr. S. Curley of MD Anderson Cancer Center initially thought that RF current/energy of the machine would heat metal nanoparticle embedded in cancer, and thus cook/destroy tumor.

However, in desperation, Mr. Kanzius started treating himself with just RF current, without any metal; lo and behold, his leukemia started receding. (Unbeknownst to him, most likely he was blocking enzyme RR thereby destroying cancer.) Mr. Kanzius was almost completely healed but unfortunately, he was made to go thru an intense chemo regime. The toxicity of the drug, according to Dr. Curley, killed him.

Dr. S. Curley kept doing studies with Kanzius machine, and after a few years, concluded that it does heal without any extra agent like metal nanoparticle. But that machine is NOT available to any cancer patient! A private company now owns it and has taken it off the market, for reasons you can guess.

Luckily, RF currents can be produced at multiple radio frequencies, including in CB radio range. Thus cancer patients can benefit from this protocol of GEIPE therapy once parameters are standardized.


Finally, why this breakthrough cancer treatment is the Most Scientific:

On May 12, 2016 in New York Times, one of the fathers of molecular biology, James Watson (of Watson-Crick DNA double helix fame) who spent 3 decades exploring genetic aspects of cancer, stated:

Locating the genes that cause cancer has been “remarkably unhelpful” … If he were going into cancer research today, he would study biochemistry rather than molecular biology.

Also note that most cancers are caused by chemicals (carcinogens) and therefore we should focus on biochemistry, rather than biology, of a cancer cell.

And according to biochemistry,

  • Whatever takes place in a biological cell is controlled by one or more enzymes.
  • For cancerous cell growth, the most critical enzyme is Ribonucleotide Reductase, RR, since it controls the rate-limiting step in DNA synthesis, without which cells cannot replicate or grow.
  • This GEIPE therapy disables RR by biophysical means. It is a non-toxic treatment with high degree of efficacy in both animals and humans. (Various cancer chemo drugs aim to block this enzyme, but with only partial success and much attendant toxicity.)
  • GEIPE treatment seems to selectively target cancer cells since active-site of enzyme RR in healthy cells is well-shielded. In malignant cells, where RR enzyme is in over-drive, due to mutations, the active-site likely becomes exposed, and thus vulnerable to a stream of electrons.
  • There is considerable evidence that cancer is initiated at the active-site of enzyme RR. (Dr. Yun Yen certainly thinks so.) Thus by targeting this enzyme, we may be nipping cancer in the bud.

We need to start a grass-root movement of concerned citizens, cancer patients, journalists and elected representatives. They should ask cancer institutions why this scientific, non-toxic and effective cancer treatment is not being established?